Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 15 citing Kosobucki: Photographic estimation of the duration of high dose intravitreal triamcinolone.... (0.11 sec) 

Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular …


VL Morrison, I Kozak, LD LaBree, SP Azen, … - Ophthalmology, 2007 - Elsevier
Cited by 11 - Related articles - All 8 versions

Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: …


… PG NEHEMY, AP SCHACHAT, MB NEHEMY - Retina, 2008 - journals.lww.com
Conclusions: A 4-mg IVTA injection was associated with SOH in 32.0% of treated
eyes. The risk of SOH was higher in eyes with previous glaucoma and higher
baseline IOP. Peak IOP after IVTA injection was lower in vitrectomized ...
Cited by 7 - Related articles - BL Direct - All 4 versions

Intraocular pressure after intravitreal injection of triamcinolone acetonide following …


T Yamashita, A Uemura, H Kita, T Sakamoto - Journal of Glaucoma, 2007 - journals.lww.com
Reprints: Takehiro Yamashita, MD, Department of Ophthalmology, Kagoshima
University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka,
Kagoshima 890-8520, Japan (e-mail: take1@m.kufm.kagoshima-u.ac.jp).
Cited by 3 - Related articles - BL Direct - All 3 versions

Objective evaluation of cataract progression associated with a high dose intravitreal …


YK Chu, EJ Chung, OW Kwon, JH Lee, HJ … - Eye, 2007 - nature.com
This prospective interventional case series study included 38 patients (76 eyes)
with diabetic retinopathy or retinal vein occlusion diagnosed with clinical
examination and fluorescein angiography. The patients were treated with 25 ...
Cited by 2 - Related articles - All 5 versions

Comparison of 4 mg versus 20 mg intravitreal triamcinolone acetonide injections

- duanessolution.com [PDF] 
AM Tammewar, L Cheng, OR Kayikcioglu, IA … - British Journal of Ophthalmology, 2008 - bjo.bmj.com
Results: Of the 92 eyes, 46% (23 of 51) in the 4 mg group versus 30% (12 of 41)
in the 20 mg group had an IOP >21 mm of Hg (p = 0.14) after a mean follow-up
period of 27 weeks. The vitrectomised eyes (3 of 24) in the 20 mg group had ...
Cited by 1 - Related articles - BL Direct - All 4 versions

Evaluation of subretinal triamcinolone acetonide in patients with exudative age-related …


I Kozak, L Cheng, I Falkenstein, AM … - Journal of Ocular Pharmacology And Therapeutics, 2007 - liebertonline.com
Purpose: The aim of this paper was to present the results of subretinal delivery
of triamci- nolone acetonide (TCA) in humans with choroidal neovascularization
(CNV) caused by age- related macular degeneration (AMD). Methods: Twenty ...
Cited by 1 - Related articles - BL Direct - All 4 versions

Acute Glaucoma Secondary To Angle Obstruction By Triamcinolone Crystals

- duanesolution.com
LT Tan, L Au, G Cormack, M Lavin - Retinal Cases and Brief Reports, 2009 - journals.lww.com
Purpose: To present a case of acute glaucoma secondary to massive transit of
triamcinolone acetonide into the anterior chamber in a pseudophakic,
vitrectomized eye following intravitreal injection for treatment of cystoid ...
Related articles - All 5 versions

[PDF] Subtenons vs. Intravitreal Triamcinolone in Refractory Diabetic Macular Oedema


MM INDIRA, Z NAEEM - Journal of Clinical and Diagnostic Research, 2007 - jcdr.net
Indira and Naeem: Subtenons vs. intravitreal triamcinolone for diabetic macular
oedema ... Journal of Clinical and Diagnostic Research. 2007Oct; 1(5):377-379
377 ... Subtenons vs. Intravitreal Triamcinolone in Refractory Diabetic ...
Related articles - View as HTML - All 4 versions

SOLUBILITY OF TRIAMCINOLONE ACETONIDE AND OTHER ANTI-INFLAMMATORY DRUGS IN …


JC PASTOR, MJ DEL NOZAL, E ZAMARRON, … - RETINA, 2008 - journals.lww.com
From the *IOBA (Eye Institute); and †Analytical Chemistry Department,
University of Valladolid, Valladolid, Spain. Supported by FIS-FEDER grant,
PI020821. The authors have no proprietary interest in any of the products ...
Related articles - All 2 versions

Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous …


SH Byeon, OW Kwon, JH Song, SE Kim, YS … - Graefe's Archive for Clinical and Experimental …, 2009 - Springer
Abstract Background To evaluate the efficacy of timolol-dorzolamide drops used
to decrease aqueous outflow from the eye on the prolongation of the biological
activity of intravitreal bevacizumab. Methods Thirty-eight eyes of 38 ...
Related articles - All 3 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google